223 related articles for article (PubMed ID: 8682429)
1. [Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].
Eisenburg J
Fortschr Med; 1996 Apr; 114(12):141-6. PubMed ID: 8682429
[TBL] [Abstract][Full Text] [Related]
2. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
5. Assessment of low-grade hepatic encephalopathy: a critical analysis.
Kircheis G; Fleig WE; Görtelmeyer R; Grafe S; Häussinger D
J Hepatol; 2007 Nov; 47(5):642-50. PubMed ID: 17869373
[TBL] [Abstract][Full Text] [Related]
6. Minimal hepatic encephalopathy.
Sharma P
J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
[TBL] [Abstract][Full Text] [Related]
7. Management options for minimal hepatic encephalopathy.
Bajaj JS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
9. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
Jindal A; Sharma BC; Sachdeva S; Chawla R; Srivastava S; Maharshi S
Dig Liver Dis; 2015 Sep; 47(9):769-74. PubMed ID: 26022229
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
[TBL] [Abstract][Full Text] [Related]
11. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice.
Schomerus H; Schreiegg J
Z Gastroenterol; 1993 Apr; 31(4):231-4. PubMed ID: 8493802
[TBL] [Abstract][Full Text] [Related]
13. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
Hendriks ME; van Westerloo DJ; Portegies P
Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
[TBL] [Abstract][Full Text] [Related]
14. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
[TBL] [Abstract][Full Text] [Related]
15. Hepatic encephalopathy: pathophysiology and advances in therapy.
Av SP
Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
[TBL] [Abstract][Full Text] [Related]
16. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
17. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
[No Abstract] [Full Text] [Related]
18. [Diagnosis and therapy of portosystemic encephalopathy].
Weissenborn K
Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1059-64. PubMed ID: 7939069
[TBL] [Abstract][Full Text] [Related]
19. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Neurol India; 2010; 58(2):220-4. PubMed ID: 20508339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
